Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × pasireotide × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Lymphoid 1 Gastrointestinal 1 Endocrine 1

Conditions

Prolactin-Producing Pituitary Tumor 1 Lymphoma, Follicular 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06784752 2026-03-06

NETTER-3

Novartis

Phase 3 Recruiting

EndocrineGastrointestinalLymphoidNET

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡